• Who we are
  • Our Board of Directors
  • CRT Inc
  • Cancer Therapeutics CRC (CTx)
  • Clinical Development Partnerships
• What we do
• Our Track Record
  • Agents in clinical development
  • Our Start-ups
  • Our Research Partners
  • Our Industry Partnerships
  • What the science community have to say
  • What the research establishments have to say
• Our History & Milestones

Our Track Record

CRT has a strong track record of successful drug discovery through the collaboration and licensing of our programmes. Our partnered therapeutics are currently marketed by AstraZeneca and Schering-Plough. A third product was progressed to market by Pfizer.